Beverly Hills Private Wealth, LLC Myriad Genetics Inc Transaction History
Beverly Hills Private Wealth, LLC
- $433 Billion
- Q1 2024
A detailed history of Beverly Hills Private Wealth, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Beverly Hills Private Wealth, LLC holds 16,797 shares of MYGN stock, worth $466,116. This represents 0.08% of its overall portfolio holdings.
Number of Shares
16,797
Previous 17,601
4.57%
Holding current value
$466,116
Previous $337 Million
6.3%
% of portfolio
0.08%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding MYGN
# of Institutions
195Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$413 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$278 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$224 Million0.03% of portfolio
-
Camber Capital Management LP Boston, MA7.64MShares$212 Million3.99% of portfolio
-
State Street Corp Boston, MA5.4MShares$150 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.24B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...